MTSR
Metsera Inc

784
Mkt Cap
$8.76B
Volume
1.92M
52W High
$83.86
52W Low
$12.30
Price
$89.00
MTSR Fundamentals
Prev Close
$81.55
Open
$81.50
50D MA
$49.99
Beta
1.72
Avg. Volume
1.88M
EPS (Annual)
-$1.99
P/B
19.42
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk
Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war against Novo Nordisk...
MarketBeat·18h ago
News Placeholder
More News
News Placeholder
Pfizer Clinches $10 Billion Deal To Buy Obesity Drug Maker Metsera, Outbidding Novo Nordisk In Fierce Battle For Weight-Loss Market Dominance
Nvidia CEO Jensen Huang cautioned Elon Musk against underestimating the challenges of semiconductor manufacturing, saying building a chip fab like TSMC's is "extremely hard."read more...
Benzinga·1d ago
News Placeholder
Pfizer Sweetens Offer For Metsera To $86.25/shr Amid Escalating Bidding War With Novo Nordisk
(RTTNews) - Metsera Inc. (MTSR) announced that it has entered into an amended merger agreement with Pfizer, under which Pfizer will acquire Metsera for up to $86.25 per share. The deal includes...
Nasdaq News: Markets·1d ago
News Placeholder
Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer
Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's...
PR Newswire·1d ago
News Placeholder
Metsera (NASDAQ:MTSR) Trading Up 10.6% - Still a Buy?
Metsera (NASDAQ:MTSR) Trading 10.6% Higher - Here's What Happened...
MarketBeat·2d ago
News Placeholder
Pfizer Discusses Drug Pricing Deal, Metsera Buyout Dispute on Q3 Call
Pfizer faces a fierce bidding war with Novo Nordisk over Metsera while securing a landmark U.S. drug pricing deal.
Zacks·2d ago
News Placeholder
Investors Purchase High Volume of Put Options on Metsera (NASDAQ:MTSR)
Metsera Inc. (NASDAQ:MTSR - Get Free Report) was the recipient of unusually large options trading on Thursday. Stock traders purchased 2,401 put options on the company. This represents an increase of...
MarketBeat·2d ago
News Placeholder
Tesla Investors Approve Musk Pay Package, Comcast's Sky in Talks to Buy ITV The Opening Trade 11/7
Tesla shareholders approved a potential $1 trillion compensation package for Chief Executive Officer Elon Musk, the largest payout ever awarded to a corporate leader. Musk would have to meet certain...
Bloomberg Markets and Finance-YouTube·2d ago
News Placeholder
Novo Nordisk Reportedly Refrains From Backing Down In Metsera Acquisition Battle, Sweetens Bid Further
According to an FT report, Pfizer now has two days to match Novo’s new bid or let its agreed-upon deal with Metsera fall through.
Stocktwits·3d ago
News Placeholder
Novo Nordisk Snaps 11-Day Losing Streak After Court Rejects Pfizer’s Challenge To $10B Metsera Deal
Delaware Chancery Judge Morgan Zurn ruled that Pfizer’s objections did not justify delaying Novo’s $10 billion acquisition of obesity-drug startup Metsera.
Stocktwits·3d ago

Latest MTSR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.